Page last updated: 2024-09-05

ensaculin and Dementia

ensaculin has been researched along with Dementia in 2 studies

*Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoerr, R; Noeldner, M1
Biber, A; Derendorf, H; Hoerr, R; Sourgens, H; Steinbrede, H1

Reviews

1 review(s) available for ensaculin and Dementia

ArticleYear
Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment.
    CNS drug reviews, 2002,Summer, Volume: 8, Issue:2

    Topics: Animals; Benzopyrans; Clinical Trials as Topic; Dementia; Humans; Memory; Neuroprotective Agents; Piperazines; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Synaptic Transmission

2002

Trials

1 trial(s) available for ensaculin and Dementia

ArticleYear
KA 672-HCl, a neuronal activator against dementia: tolerability, safety, and preliminary pharmacokinetics after single and multiple oral doses in healthy male and female volunteers.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:4

    Topics: Administration, Oral; Aged; Benzopyrans; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines

1998